Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Tor-Arne Hegvik, Kai Waløen, Sunil K. Pandey, Stephen V. Faraone, Jan Haavik, Tetyana Zayats

Journal title: Molecular Psychiatry

Journal publisher: Nature Publishing Group

Published year: 2019

DOI identifier: 10.1038/s41380-019-0540-z

ISSN: 1359-4184